Company Overview of Ganeden, Inc.
Ganeden, Inc. manufactures and supplies probiotics and probiotic bacteria. The company licenses probiotic technology for use in products in a range of applications, including functional probiotic foods and beverages, probiotic supplements, and topical applications; and feed additives for use in animal health and livestock production. It offers GanedenBacillus coagulans for food, beverage, or companion animal applications; and Bonicel, a probiotic-derived personal care ingredient for anti-aging creams, gels, masks, serums, body lotions, cosmetics, and hair care products. The company’s products are available online and stores across the United States. It has a strategic alliance with Sensus Am...
5800 Landerbrook Drive
Mayfield Heights, OH 44124
Founded in 1997
Key Executives for Ganeden, Inc.
Compensation as of Fiscal Year 2016.
Ganeden, Inc. Key Developments
Ganeden Receives Regulatory Approvals for GRAS for Infants
Jan 18 17
Ganeden continues its trend of being the first to receive regulatory approvals with the announcement that GanedenBC30® (Bacillus coagulans GBI-30, 6086) is FDA GRAS for infant formulas. Already known as the leading probiotic ingredient for functional foods and beverages, GanedenBC30 is now expanding its formulation opportunities into the new space. While the probiotic supplier's previous FDA GRAS certification covered products that could be fed to infants and children, the newest approval allows the strain to be the first and only spore-former to be used specifically in infant formulas. An independent and critical evaluation was performed reviewing the safety of GanedenBC30 relating to usage in infant formulas. The evaluation was conducted by a panel of safety experts, including the Chair of the Department of Pediatrics at Massachusetts General Hospital and Harvard Professor, and overseen by AIBMR. Scientific research on Ganeden's strain was evaluated and the panel unanimously determined that GanedenBC30 is GRAS for use in infant formula. After receiving Self-affirmed GRAS in the Fall of 2016, the international ingredient supplier submitted a notification to the FDA for use in infant formula, which has now received a no objection letter. Probiotics have become increasingly popular in infant products as awareness continues to rise around the importance of boosting beneficial bacteria from the start of life. Babies are born with sterile digestive tracts, and a variety of factors can affect the natural gut flora and the development of their digestive system. GanedenBC30 was the first Bacillus strain to receive GRAS directly from the FDA for adult usage, and has already been formulated into more than 550 probiotic foods and beverages worldwide, including a variety of children's products. The ingredient supplier is now in discussions with leading companies in the infant category to discuss new probiotic developments.
Ganeden Promotes Michael Bush to President
May 18 16
Ganeden has promoted Michael Bush to president of the company. The new president has led the field as both executive board president for the International Probiotics Association and as a speaker and media spokesperson. Promoted from vice president, the new role is intended to allow Bush to concentrate on the company's strategic business development and help manage its growth, both domestically and internationally. He will also continue to manage sales and marketing activities, while maintaining his position as an expert source for media quotes, speaking engagements and educational opportunities. Prior to joining Ganeden, he had more than 20 years of business experience and has won numerous awards for business leadership.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries